Nephros, Inc.
NEPH
$3.58
$0.113.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.25% | 32.67% | 32.36% | 21.16% | 10.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.25% | 32.67% | 32.36% | 21.16% | 10.34% |
| Cost of Revenue | 31.46% | 31.72% | 24.90% | 12.01% | 4.39% |
| Gross Profit | 18.31% | 33.27% | 37.13% | 27.17% | 14.26% |
| SG&A Expenses | 18.99% | 17.25% | 4.15% | -6.75% | -12.78% |
| Depreciation & Amortization | -7.80% | 3.70% | -6.58% | -17.92% | -26.94% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.11% | 24.63% | 13.64% | 1.37% | -5.18% |
| Operating Income | -12.31% | 19,000.00% | 250.52% | 197.66% | 151.92% |
| Income Before Tax | -3.43% | 1,255.06% | 262.33% | 204.40% | 156.75% |
| Income Tax Expenses | -20.00% | -20.00% | -- | -- | -- |
| Earnings from Continuing Operations | -3.12% | 1,513.51% | 259.42% | 202.55% | 155.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.12% | 1,513.51% | 259.42% | 202.55% | 155.70% |
| EBIT | -12.31% | 19,000.00% | 250.52% | 197.66% | 151.92% |
| EBITDA | -12.24% | 798.60% | 296.65% | 223.89% | 170.77% |
| EPS Basic | -3.31% | 1,531.88% | 257.90% | 201.70% | 154.82% |
| Normalized Basic EPS | -3.74% | 1,292.16% | 260.36% | 203.37% | 155.74% |
| EPS Diluted | -6.67% | 21,060.00% | 240.11% | 191.01% | 148.82% |
| Normalized Diluted EPS | -6.65% | 1,268.63% | 258.38% | 202.98% | 155.74% |
| Average Basic Shares Outstanding | 0.75% | 0.86% | 0.76% | 0.79% | 1.07% |
| Average Diluted Shares Outstanding | 4.23% | 3.62% | 2.25% | 1.44% | 1.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |